Your browser doesn't support javascript.
loading
Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor.
Fasih, Samir; Suppiyah, Suganth; Barron, Jane; Barnett-Tapia, Carolina; Avery, Roger; Dickson, Brendan; Ferguson, Peter; Swallow, Carol; Zadeh, Gelareh; Gupta, Abha A.
Affiliation
  • Fasih S; Division of Medical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Suppiyah S; Division of Neurosurgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Barron J; Discipline of Laboratory Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
  • Barnett-Tapia C; Division of Neurosurgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Avery R; Department of Surgery, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
  • Dickson B; Department of Pathology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Ferguson P; Department of Orthopedic Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Swallow C; Department of General Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Zadeh G; Division of Neurosurgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Gupta AA; Division of Medical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
Neurooncol Adv ; 3(1): vdab033, 2021.
Article in En | MEDLINE | ID: mdl-33959714
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2021 Type: Article